Photoacoustic Tomography Market Size & Share 2025 - 2034

Photoacoustic Tomography Market Size

The global photoacoustic tomography market was valued at USD 61 million in 2024. The market is expected to reach from USD 70.5 million in 2025 to USD 275.3 million in 2034, growing at a CAGR of 16.3% during the forecast period. Photoacoustic tomography (PAT) is an imaging method that combines light and sound to capture detailed images of deep tissues.

The growing prevalence of chronic disease such as cancer is one of the key catalysts for the growth of the market with necessities the need for sophisticated imaging to support early detection and accurate diagnosis. For instance, the World Health Organization (WHO) reported 9.7 million deaths due to cancer and approximately 20 million new cases of cancer globally in February 2022.
 

Additionally, the increasing requirement for non-invasive and precision medicine, projected to exceed USD 157.1 billion by 2032, is drawing significant attention toward the market and is making early disease detection efforts far more efficient. A notable example of this trend was the introduction of a new ultra-high to low-frequency ultrasound imaging system by FUJIFILM VisualSonics in 2024. This development plays a vital role in improving patient care and propelling market expansion by enabling prompt and accurate diagnostics.
 

Additionally, breast cancer continues to be an important health concern globally. Based on the American Cancer Society's projections for 2024, it was projected that 42,780 people will die from breast cancer in the U.S. among them 42,250 will be women and 530 men. Thus, these kinds of disease conditions often require precise and swift diagnosis to initiate prompt treatment and improve patient outcomes. Photoacoustic tomography offers unique advantages by providing high-resolution, instant images that combine the benefits of optical imaging with the depth penetration of ultrasound, thereby propelling the growth of the market.
 

Photoacoustic Tomography Market Trends

• The healthcare industry is rapidly shifting toward earlier and more precise treatments. At this point, both patients and practitioners recognize the value in early intervention and detection, which has driven the use of imaging technologies, like photoacoustic imaging, to new levels. Photoacoustic imaging is non-invasive and allows for visualization of tissue structures and functions. This is of great aid for diagnosing serious conditions like cancer, cardiovascular disease, and neurological disorders.
   
• An important advancement is the Seno Medical Imagio Breast Imaging System, which was released in November 2022. This sophisticated system enables physicians to non-invasively perform ultrasound guided differentiation of benign from malignant breast lesions and emphasizes the role of photoacoustic imaging, like photoacoustic tomography, in cancer diagnosis.
   
• In addition, the ongoing advancement in the healthcare industry is expected to greatly support market growth with the integration of photoacoustic tomography and other novel technologies. With ongoing R&D, the prospects of furthering the photoacoustic tomography are promising and aim at developing greater non-invasive diagnostic procedures and customized care options for patients.
   

Trump Administration Tariffs

• The tariffs placed on Chinese imports like optical sensors, semiconductors, and electronic parts during the Trump presidency are expected to drive up the cost of materials needed to make photoacoustic tomography (PAT) systems.
   
• A lot of PAT device makers currently rely on Chinese suppliers for affordable parts such as photodetectors, fiber-optic cables, and circuit boards. Because of the tariffs, these companies could face supply chain disruptions and higher manufacturing costs.
   
• To deal with this, many PAT companies may need to rethink their supply chains and shift to sourcing components from other countries like South Korea, Japan, Germany, or parts of Eastern Europe places that offer high-quality parts and more stable trade relationships.
   
• In the short term, these changes are expected to incur challenges such as delays in component availability, increase in the production costs owing to supplier diversification, and possible interruptions in support services for key parts of the system such as imaging modules, control interfaces, and laser integration.
   

Photoacoustic Tomography Market Analysis

Based on the study type, market is segmented into clinical study and pre-clinical study. The pre-clinical segment dominated the market with a market share of 82.8% in 2024.
 

• Pre-clinical studies are crucial for the examination and development of innovative medical technologies such as diagnostic devices and therapies as these studies precede clinical trials. These investigations are conducted in controlled environments to ascertain safety, efficacy, and biological mechanisms before clinical trials commence.
   
• Additionally, there is an increasing need for pre-clinical studies with the expansion of the biotechnology, medical device, and pharmaceutical industries, as these companies rely heavily on research activities to gather vital information for regulatory approval and refine the clinical trial process. The risk of failure during the later stages of development significantly rises if the comprehensive pre-clinical studies are avoided.
   
• Technological advancements is driving the expansion in the pre-clinical research field, with photoacoustic tomography (PAT) being a major contributor. This non-invasive imaging technique is gaining wide acceptance among researchers working with small animal models, particularly in the cancer investigation, making it a popular choice.
   
• PAT's ability for high-resolution imaging and deep tissue penetration facilitates early disease identification, drug development, and treatment monitoring, thus propelling their expansion in the pre-clinical research sector.

Learn more about the key segments shaping this market

Download Free PDF

Based on the application, photoacoustic tomography market is segmented into functional brain imaging, tumor angiogenesis, blood oxygenation mapping, skin melanoma detection, and other applications. The tumor angiogenesis segment dominated the market with a market share of 33% in 2024.
 

• Tumor angiogenesis denotes the process of new blood vessel formation surrounding tumor’s, which is essential for tumor growth and metastasis. Photoacoustic tomography is especially useful in this field as it enables the real-time visualization of blood vessel structures and tumor angiogenesis, assisting in the early detection and observation of cancer progression.
   
• The increasing global cancer burden has stimulated significant research into tumor microenvironments. For example, in 2022, lung cancer remained the most prevalent type of cancer worldwide, with 2.5 million new cases, constituting roughly 12.4% of all new cancer cases, according to the IARC’s Global Cancer Observatory. Female breast cancer followed, coming in second with 2.3 million cases (11.6%); subsequently, colorectal cancer with 1.9 million cases (9.6%), prostate cancer with 1.5 million cases (7.3%), and stomach cancer with around 970 thousand new cases which was 4.9% of the total. Therefore, the need for research in pre-clinical and clinical settings, with the use of PAT to study tumor angiogenesis for these cancers, is rapidly growing. 
   
• Moreover, studies also indicates that the accuracy of diagnostic imaging for tumors is significantly improved with the use of photoacoustic tomography for imaging the tumor blood vessels. 
   
• Consequently, The need for real-time imaging that is non-invasive, high in resolution, and provides high definition continues to grow, and so does the expectation for photoacoustic tomography as an important asset in cancer diagnostics pertaining to tumor angiogenesis as well as treatment planning.
   

Based on the end use, photoacoustic tomography market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and other end users. The hospitals segment held revenue of USD 20.9 million in 2024, and the segment is poised for significant growth at a CAGR of 16.7% during the forecast period.
 

• Hospitals are one of the major end users of photoacoustic tomography systems, propelled by the rising need for non-invasive, high-resolution imaging methods in medical environments.
   
• The inclusion of PAT in hospital diagnostics is anticipated to improve the identification and tracking of diverse medical conditions, such as cancer, heart diseases, and neurological disorders. This integration is expected to enhance diagnostic precision and patient’s outcome, thus aiding the growth of the segment
   
• The adoption of photoacoustic tomography in medical facilities is also affected by improvements in laser and ultrasound technologies that have boosted the performance of PAT systems.
   
• Hence, the hospitals sector is set for significant expansion in the market, fuelled by technological progress, rising disease incidence, and the demand for advanced diagnostic instruments in healthcare settings.

The U.S. photoacoustic tomography market is forecasted to reach USD 113.1 million by 2034.

• The U.S. hold significant market share within the North American market, stimulated by ongoing technological advancements and an increasing emphasis on patient-focused healthcare options.
   
• Prominent research institutions in the U.S. are undertaking investigations to investigate and enhance the uses of photoacoustic tomography. For example, a study found in PubMed Central Associated of National Institutes of Health reviews that the advanced technological platforms are increasingly being used in the U.S to detect early stages bladder cancer using photoacoustic imaging.
   
• Furthermore, the U.S. authorities are investing in the healthcare services and technologies to strengthen the capability of making sophisticated diagnoses. The Department of Health and Human Services (HHS) reported spending USD 144.3 billion from discretionary funds and USD 1.7 trillion to enhance the health and welfare of individuals in the U.S. At the same time, hospitals are progressively integrating advanced technologies to enhance patient care, which is fuelling market expansion.
   

Europe: The photoacoustic tomography market in the UK is projected to grow significantly from 2025 to 2034.
 

• The market in UK is experiencing significant growth, stimulated by the rising prevalence of chronic conditions such as cancer, cardiovascular disease, among others. For instance, in 2021 there were 395,181 cases of cancer in the UK of these, 200,870 were in men and 194,311 in women.
   
• The rising incidence of cancer is expected to drive the demand for advanced imaging techniques such as photoacoustic tomography in cancer-related diagnostics in the country.
   
• Moreover, a number of UK-based, as well as EU collaborative projects, such as INNODERM Project, are working on the development of hybrid imaging platforms which combine PAT with ultrasound, MRI, and CT making them highly relevant for clinical translation.
   

Asia Pacific: The photoacoustic tomography market in the Japan is projected to grow significantly from 2025 to 2034.
 

• Japan's dedication to enhancing healthcare standards and improving patient outcomes positions PAT as a valuable asset in the evolving healthcare landscape.
   
• Japan's medical system is based on "patient-centeredness," focusing on providing the "correct diagnosis and optimal treatment. Moreover, AI tools trained on country-specific data and local compute infrastructure are enhancing the abilities of clinicians and researchers.
   
• These programs demonstrate Japan's commitment to improving healthcare standards and incorporating cutting-edge technologies, making tools such as photoacoustic tomography important resources in the changing healthcare environment, stimulating the market growth in the country.
   

Middle East and Africa: The Saudi Arabia photoacoustic tomography market is projected to grow significantly from 2025 to 2034.
 

• The growth of the market is high influenced by the increasing investment in healthcare infrastructure, including advanced medical imaging device, such as photoacoustic tomography is propelling the growth of the market in the country.
   
• For instance, Saudi Arabia's Vision 2030 includes significant investments in healthcare infrastructure, which are aimed at enhancing the quality and accessibility of medical services across the country as part of this initiative, the country is addressing the growing demand for advanced diagnostic and imaging technologies, particularly as the incidence of cancer continues to rise.
   
• The number of new cancer cases in Saudi Arabia is projected to increase from 27,885 in 2020 to 60,429 by 2040, reflecting a substantial rise in cancer incidence. Among the most common cancers, breast cancer has emerged as the most prevalent in females across the country, with an incidence rate of 25.3 per 100,000 persons in 2022.
   
• Thus, the increasing prevalence of cancer cases in the country is accelerating the need for innovative technologies such as photoacoustic tomography (PAT) to support early detection, improve diagnostic accuracy, and enhance treatment planning in the fight against cancer.
   

Photoacoustic Tomography Market Share

The market for photoacoustic tomography (PAT) is competitive, with both established players and new entrants actively innovating and developing advanced imaging technologies. In terms of market share, the market is primarily dominated by top 3 leading companies such as Advantest, Fujifilm VisualSonics, and Seno Medical Instruments, which together account for approximately 35% of the total market share.
 

These companies are focusing on the development of advanced PAT systems, including high-resolution imaging and deeper tissue penetration, to enhance diagnostic accuracy and provide real-time, non-invasive imaging solutions, thereby strengthening their position in this rapidly growing sector. Smaller firms such as TomoWave Laboratories and Kibero GmbH are helping innovate through custom-developed photoacoustic imaging systems and R&D driven modular parts.
 

Photoacoustic Tomography Market Companies

Some of the eminent market participants operating in the photoacoustic tomography industry include:

• Advantest
• Aspectus
• Fujifilm VisualSonics
• iThera Medical
• Kibero
• Seno Medical Instruments
• TomoWave
• Vibronix
   
• Advantest, with a strong global workforce of 7,358 employees, 2,819 in Japan and 4,539 internationally as of March 31, 2024, demonstrates its global reach and technical expertise.
   
• Seno Medical sets itself apart through its groundbreaking Imagio Breast Imaging System, FDA-approved imaging platform that combines opto-acoustic and ultrasound technology to provide functional, non-invasive, and radiation-free breast cancer diagnostics.
   
• Fujifilm VisualSonics has a specific focus on small animal imaging, drug discovery, vascular biology, oncology. Companies products are widely adopted across academic and preclinical laboratories across the globe, as the company focuses towards offering integrated hybrid imaging systems for use in translational research.
   

Photoacoustic Tomography Industry News:

• In January 2023, Seno Medical entered into its first exclusive distributor agreement with Genetik, Inc. to market, sell, and service the company’s innovative Imagio Opto-Acoustic/Ultrasound (OA/US) Breast Imaging System. Under this agreement, Genetik will oversee regional distribution in Singapore, where it is headquartered. This strategic initiative marked a key step in Seno Medical’s global expansion efforts, enabling the company to extend its geographic footprint and access new international markets for its advanced breast imaging technology.
   

The photoacoustic tomography market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Study Type

• Clinical study
• Pre-clinical study

Market, By Application

• Functional brain imaging
• Tumor angiogenesis
• Blood oxygenation mapping
• Skin melanoma detection
• Other applications

Market, By End Use

• Hospitals
• Diagnostic imaging centers
• Academic and research laboratories
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE